• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ophiobolin B

Ophiobolin B

Product ID O610292
Cas No. 5601-74-1
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $374.90 In stock
5 mg $1,430.90 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ophiobolin B is a naturally occurring sesterterpenoid. The ophiobolin family is known to exhibit a broad spectrum of inhibitory activity against several cell lines. Both ophiobolins A and B have also shown antifungal activity against several fungal strains.

Product Info

Cas No.

5601-74-1

Purity

≥98%

Formula

C25H38O4

Formula Wt.

402.58

Chemical Name

Ophiobolin B

IUPAC Name

(1~{R},3~{S},4~{R},7~{S},8~{E},11~{R},12~{S})-4,12-dihydroxy-1,4-dimethyl-12-[(2~{S})-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0^{3,7}]tetradec-8-ene-8-carbaldehyde

Synonym

Cochliobolin B; 3,14-Dihydroxy-5-oxoophiobola-7,19-dien-25-al; CHEMBL478388; Ophiobola-7,19-dien-25-al, 3,14-dihydroxy-5-oxo-

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

O610292 MSDS PDF

Info Sheet

O610292 Info Sheet PDF

References

Bladt TT, Durr C, Knudsen PB, et al. Bio-activity and dereplicaiton-based discovery of ophioblins and other fungal secondary metabolites targeting leukemia cells. Molecules. 2013 Nov 26;18(12):14629-14650. PMID: 24287995.

Krizsan K, Bencsik O, Nyilasi I, et al. Effect of the sesteterpene-type metabolites, ophiobolins A and B, on zygomycetes fungi. FEMS Microbiol Lett. 2010 Dec;313(2):135-140. PMID: 21054501.

Li E, Clark AM, Rotella DP, et al. Microbial metabolites of ophiobolin A and antimicrobial evaluation of ophiobolins. J Nat Prod. 1995 Jan;58(1):74-81. PMID: 7760080.

Gianani L, Cocucci S, Pardi D, et al. Effects of ophiobolin B on cell enlargement and H(+)/K(+) exchange in maize coleoptile tissues. Planta. 1979 Jan;146(3):271-274. PMID: 24318178.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S0929

    SCH-772984

    ERK1/2 inhibitor.

    ≥97%
  • V0269

    Vardenafil Dihydrochloride

    PDE5 inhibitor.

    ≥99%
  • G7241

    GSK-461364

    PLK1 inhibitor.

    ≥99%
  • B5000

    BMS-911543

    JAK2 inhibitor.

    ≥99%
  • C0020

    Cafestol

    Diterpene found in brewed, unfiltered coffee; F...

    ≥98%
  • A5313

    Andrographolide

    Labdane diterpene found in Andrographis; RLR (R...

    ≥98%
  • N5605

    Nobiletin

    Polymethoxylated flavone found in citrus fruits...

    ≥97%
  • B6800

    Bradykinin Triacetate

    Natriuretic, vasodilatory peptide; B1/2 agonist...

    ≥95%
  • T0004

    T2 toxin Triol

    Trichothecene mycotoxin produced by Fusarium; p...

    ≥97%, TLC
  • T0205

    3”,4”-Dehydropaclitaxel C

    Semi-synthetic taxane.

    ≥95%
  • D336486

    Dimethylamino Parthenolide

    Water-soluble parthenolide analog; NF-κB inhib...

    ≥98%
  • L3326

    Ligustrazine Hydrochloride

    Dihydropyrazine found in Ligusticum walliichi. ...

    ≥98%
  • M5877

    Motesanib Diphosphate

    VEGFR, PDGFR, c-Kit, RET inhibitor.

    ≥98%
  • N3350

    Nimorazole

    Nitroimidazole; hypoxic modifier and radiosensi...

    ≥98%
  • P0369

    Parecoxib Sodium

    NSAID; COX-2 inhibitor.

    ≥99%
  • M2400

    MG-132

    Proteasome inhibitor.

    ≥98%
  • T2402

    TG100-115

    p110δ and p110γ PI3K inhibitor.

    ≥98%
  • C0162

    Capecitabine

    5-FU prodrug; thymidylate synthase inhibitor.

    ≥98%
  • A4853

    β-Amyloid Peptide (1-42), human

    Endogenous APP peptide cleavage product, primar...

    ≥95%
  • G8850

    GW-5074

    c-Raf inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only